Integrated models of care in managing inflammatory bowel disease: A discussion

Inflammatory Bowel Diseases

Volumn 18, Issue 8, 2012, Pages 1582-1587

  Mikocka Walus, Antonina A ^a,b   Andrews, Jane M ^b,c   Bernstein, Charles N ^d   Graff, Lesley A ^d   Walker, John R ^d   Spinelli, Antonino ^e,f   Danese, Silvio ^e   Van Der Woude, C Janneke ^g   Goodhand, James ^h   Rampton, David ^h   Moser, Gabriele ⁱ  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d UNIVERSITY OF MANITOBA   (Canada)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

biopsychosocial; inflammatory bowel disease; integrated model of care; psychotherapy

Indexed keywords

BEHAVIOR THERAPY; COGNITIVE THERAPY; DISEASE MODEL; ENTERITIS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; MEDICAL PRACTICE; MEDICAL SPECIALIST; NURSE; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; WORLD HEALTH ORGANIZATION;

DELIVERY OF HEALTH CARE, INTEGRATED; DISEASE MANAGEMENT; HUMANS; INFLAMMATORY BOWEL DISEASES; STANDARD OF CARE; WORLD HEALTH;

EID: 84863987275     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22877     Document Type: Review

References (48)

1. Grone O, Garcia-Barbero M,. Integrated care: a position paper of the WHO European Office for Integrated Health Care Services. Int J Integr Care. 2001; 1: e21.
2. Bolibar I, Plaza V, Llauger M, et al. Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease. BMC Public Health. 2009; 9: 68.
3. de Stampa M, Vedel I, Mauriat C, et al. Diagnostic study, design and implementation of an integrated model of care in France: a bottom-up process with continuous leadership. Int J Integr Care. 2010; 10: e034.
4. Vedel I, De Stampa M, Bergman H, et al. A novel model of integrated care for the elderly: COPA, Coordination of Professional Care for the Elderly. Aging Clin Exp Res. 2009; 21: 414-423.
5. Renders CM, Halberstadt J, Frenkel CS, et al. Tackling the problem of overweight and obesity: the Dutch approach. Obes Facts. 2010; 3: 267-272.
6. Lloyd J, Wait S,. Integrated care: a guide for policy makers. London: Alliance for Health and the Future; 2005. Available from:.
7. Arseneau KO, Yeaton P, Kahaleh M, et al. Effect of digestive health care services integration on resource use and outcomes in patients with digestive disorders. Clin Gastroenterol Hepatol. 2003; 1: 145-151.
8. Gerson CD, Gerson MJ,. A collaborative health care model for the treatment of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2003; 1: 446-452.
9. Quality care: service standards for the healthcare of people who have inflammatory bowel disease. The IBD Standards Group; 2009. Available from:.
10. Sack C, Phan VA, Grafton R, et al. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. J Crohns Colitis. 2011 [Epub ahead of print].
11. Engel GL,. The need for a new medical model: a challenge for biomedicine. Science. 1977; 196: 129-136.
12. Engel GL,. The clinical application of the biopsychosocial model. Am J Psychiatry. 1980; 137: 535-544.
13. Bryant RV, van Langenberg DR, Holtmann GJ, et al. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol. 2011; 26: 916-923.
14. Mikocka-Walus A, Clarke D, Gibson P,. Can antidepressants influence the course of inflammatory bowel disease (IBD)? The current state of research. Eur Gastroenterol Hepatol Rev. 2009; 5: 48-53.
15. Mikocka-Walus A, Gordon A, Stewart B, et al. A magic pill? A qualitative analysis of patients' views on the role of antidepressants in inflammatory bowel disease (IBD). BMC Gastroenterol. 2011 [Epub ahead of print].
16. Mikocka-Walus A, Turnbull DA, Andrews JM, et al. The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008; 28: 475-483.
17. Mikocka-Walus A, Turnbull DA, Moulding NT, et al. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemol Ment Health. 2006; 2: 24.
18. Mikocka-Walus A, Turnbull DA, Moulding NT, et al. "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterol. 2007; 7: 38.
19. Mikocka-Walus A, Gordon A, Stewart B, et al. The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit. J Psychosom Res. 2011 [Epub ahead of print].
20. Mikocka-Walus AA, Turnbull DA, Andrews JM, et al. Psychological problems in gastroenterology outpatients: a South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C. Clin Pract Epidemol Ment Health. 2008; 4: 15.
21. Mikocka-Walus AA, Turnbull DA, Andrews JM, et al. Does doctors' knowledge of IBD patients' psychological status affect patients' clinical outcomes: a pilot RCT. Eur J Gastro Hepatol. 2009; 21: 484-485.
22. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study. Biopsychosoc Med. 2008; 2: 11.
23. van Langenberg DR, Lange K, Hetzel DJ, et al. Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change. J Gastroenterol Hepatol. 2010; 25: 1250-1258.
24. Mikocka-Walus AA, Bond M, Holloway R, et al. Does cognitive-behavioural therapy (CBT) improve outcomes in inflammatory bowel disease (IBD)? Initial feasibility report on a pilot randomised controlled trial. Gastroenterology. 2010; 138: s521-522; Dig Dis Week 2010, presentation T1253.
25. Van Langenberg DR, Simon SB, Holtmann G, et al. The burden of inpatient costs in inflammatory bowel disease and opportunities to optimise care: a single metropolitan Australian center experience. J Crohns Colitis. 2010; 4: 413-421.
26. Mikocka-Walus A, Turnbull D, Holtmann G, et al. An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation. Inflamm Bowel Dis. 2011 [Epub ahead of print].
27. Goodhand J, Dawson R, Hefferon M, et al. Inflammatory bowel disease in young people: the case for transitional clinics. Inflamm Bowel Dis. 2010; 16: 947-952.
28. Goodhand J, Hedin CR, Croft NM, et al. Adolescents with IBD: the importance of structured transition care. J Crohn's Colitis. 2011; 5: 509-519.
29. Irving PM, Rampton DS, Shanahan F,. Clinical Dilemmas in Inflammatory Bowel Disease. London: Blackwell Scientific; 2006.
30. Wahed M, Corser M, Goodhand JR, et al. Does psychological counseling alter the natural history of inflammatory bowel disease? Inflamm Bowel Dis. 2010; 16: 664-669.
31. Wahed M, Goodhand JR, West O, et al. Tobacco dependence and awareness of health risks of smoking in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011; 23: 90-94.
32. Goodhand JR, Greig FIS, Koodun Y, et al. Do antidepressants influence disease course in IBD? A retrospective case-matched observational study. Inflamm Bowel Dis. 2011 [Epub ahead of print].
33. Langmead L, Rampton DS,. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 2006; 23: 341-349.
34. Angelucci E, Orlando A, Ardizzone S, et al. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. Eur J Gastroenterol Hepatol. 2009; 21: 1036-1041.
35. Rutella S, Fiorino G, Vetrano S, et al. Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. Am J Gastroenterol. 2011; 106: 762-770.
36. Spinelli A, Sacchi M, Fiorino G, et al. Risk of postoperative recurrence and postoperative management of Crohn's disease. World J Gastroenterol. 2011; 17: 3213-3219.
37. Baars JE, Markus T, Kuipers EJ, et al. Patients' preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study. Digestion. 2010; 81: 113-119.
38. Baars JE, Siegel CA, Kuipers EJ, et al. Patient's perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel disease. Digestion. 2009; 79: 30-35.
39. Baars JE, Zelinkova Z, Mensink PB, et al. High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study. Aliment Pharmacol Ther. 2009; 30: 864-872.
40. Baars JE, Siegel CA, van't Spijker A, et al. Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis. 2010; 42: 777-784.
41. Vogelaar A, van't Spijker A, Kuipers EJ, et al. Fatigue management in IBD patients. J Crohns Colitis. 2011 [Epub ahead of print].
42. Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006; 4: 1491-1501.
43. Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008; 103: 1989-1997.
44. Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010; 105: 1994-2002.
45. Miehsler W, Weichselberger M, Offerlbauer-Ernst A, et al. Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10: 637-645.
46. Miehsler W, Dejaco C, Moser G,. Factor analysis of ADAPT questionnaire for assessment of subjective need for psychological interventions. Inflamm Bowel Dis. 2008; 14: 142-143.
47. Miehsler W, Weichselberger M, Offerlbauer-Ernst A, et al. Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis. 2008; 14: 1273-1280.
48. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004; 66: 79-84.